Tests
There are, in fact, no reliable tests available at this time to screen people who have no symptoms but may have been exposed to a bioterrorism agent. However, there are rapid molecular assays available through State Public Health Laboratories to detect Category A bioterrorism agents in people who are showing signs and symptoms of infection. Within months of the first anthrax attacks, for example, a rapid anthrax test was developed. This test has been approved by the FDA as an investigational test for use on human specimens.
Today, the U.S. government as well as the research community and industry are working aggressively to develop quick and effective methods to protect people against agents such as Bacillus anthracis (the cause of anthrax) that could be used in another bioterrorist attack. In addition, where possible, research is being focused on developing and/or improving vaccines as an effective public health protective measure.
On a broader scale, laboratories around the country are working together as part of a response network [see article on the Laboratory Response Network] to ensure that, in the event of a bioterrorist attack or other public health emergency, our labs are prepared to act quickly with the appropriate tests for identifying the cause of any illnesses so that rapid treatment can follow.
On This Site